These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17477035)

  • 61. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
    Honsová E; Sticová E; Sperl J
    Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha].
    Drózdz W; Ziółkowska-Kochan M; Kozielewicz D; Dybowska D; Borkowska A; Halota W
    Przegl Epidemiol; 2008; 62(1):93-100. PubMed ID: 18536230
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pulmonary embolism in a 30 year-old man with chronic hepatitis C during therapy with pegylated interferon-α and ribavirin].
    Elikowski W; Małek M; Kurosz J; Bereszyńska I; Marszałek A; Zawilska K; Mozer-Lisewska I
    Kardiol Pol; 2010 Nov; 68(11):1261-5. PubMed ID: 21108207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tubo-ovarian abscess during therapy of chronic hepatitis C with pegylated interferon and ribavirin.
    Inglot M; Szymczak A; Fleischer-Stepniewska K; Fleischer M; Staszek-Zurowska B; Gladysz A
    Neuro Endocrinol Lett; 2011; 32(1):1-3. PubMed ID: 21407153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
    J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interstitial pneumonitis in a patient with chronic hepatitis C and chronic renal failure on interferon therapy.
    Kang EJ; Kim DK; Jeon SR; Choi HS; Jeong SW; Jang JY; Lee JS; Uh ST
    Korean J Gastroenterol; 2011 Jul; 58(1):47-52. PubMed ID: 21778804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Repeated episodes of fixed eruption 3 months after discontinuing pegylated interferon-alpha-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Sato M; Sueki H; Iijima M
    Clin Exp Dermatol; 2009 Dec; 34(8):e814-7. PubMed ID: 19817760
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Induced interstitial pneumonitis: role of pegylated interferon alpha 2b].
    Rocca P; Dumortier J; Tanière P; Duperret S; Vial T; Cottin V; Delafosse B; Scoazec JY; Boillot O
    Gastroenterol Clin Biol; 2002 Apr; 26(4):405-8. PubMed ID: 12070414
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case of chronic hepatitis C patient of myocardial ischemia accompanied with interstitial pneumonia induced by pegylated interferon alpha-2a.
    Qu C; Zheng Z; Liu W; Jiao J; Zhu J
    Int J Clin Exp Pathol; 2014; 7(8):5232-5. PubMed ID: 25197402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient.
    Johnson K; Sargent LA; Galizio C; Ubogu EE
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1110-4. PubMed ID: 19047844
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.
    van Zonneveld M; Flink HJ; Verhey E; Senturk H; Zeuzem S; Akarca US; Cakaloglu Y; Simon C; So TM; Gerken G; de Man RA; Hansen BE; Schalm SW; Janssen HL;
    Aliment Pharmacol Ther; 2005 May; 21(9):1163-71. PubMed ID: 15854180
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Sarcoidosis during the treatment of hepatitis C by interferon-alpha and ribavirin: 2 cases].
    Lévêque L; de Boulard A; Bielefeld P; Sgro C; Hillon P; Gabreau T; Champigneulle B; Makki H; Besancenot JF
    Rev Med Interne; 2001 Dec; 22(12):1248-52. PubMed ID: 11794896
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cutaneous necrosis after injection of polyethylene glycol-modified interferon alfa.
    Dalmau J; Pimentel CL; Puig L; Peramiquel L; Roé E; Alomar A
    J Am Acad Dermatol; 2005 Jul; 53(1):62-6. PubMed ID: 15965422
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An extremely rare case of delusional parasitosis in a chronic hepatitis C patient during pegylated interferon alpha-2b and ribavirin treatment.
    Robaeys G; De Bie J; Van Ranst M; Buntinx F
    World J Gastroenterol; 2007 Apr; 13(16):2379-80. PubMed ID: 17511042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy.
    Bettoli V; Mantovani L; Boccia S; Virgili A
    Acta Derm Venereol; 2006; 86(3):258-9. PubMed ID: 16710591
    [No Abstract]   [Full Text] [Related]  

  • 76. Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.
    Sato A; Yamauchi M; Yamada T; Kumano R; Adachi K; Ishii T; Hayashi M; Kumon D
    Clin J Gastroenterol; 2014 Aug; 7(4):355-60. PubMed ID: 25132867
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.
    Pompili M; Pizzolante F; Larocca LM; Covino M; Rapaccini GL; Gasbarrini G
    Dig Liver Dis; 2006 May; 38(5):352-4. PubMed ID: 16169782
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy].
    Domínguez Gozalo A; Hidalgo Correas FJ; García Benayas E; García Díaz B
    Farm Hosp; 2015 May; 39(3):186-8. PubMed ID: 26005896
    [No Abstract]   [Full Text] [Related]  

  • 79. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
    López V; Molina I; Monteagudo C; Jordá E
    Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pancreatitis induced by pegylated interferon alfa-2b in a patient affected by chronic hepatitis C.
    Cecchi E; Forte P; Cini E; Banchelli G; Ferlito C; Mugelli A
    Emerg Med Australas; 2004; 16(5-6):473-5. PubMed ID: 15537413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.